Lessons from S1P receptor targeting in multiple sclerosis-Reference-Cited by-同舟云学术

Lessons from S1P receptor targeting in multiple sclerosis

Published:2022-02 Issue: Volume:230 Page:107971
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Colombo Emanuela,Farina Cinthia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference176 articles.

1. An immunological and transcriptomics approach on differential modulation of NK cells in multiple sclerosis patients under interferon-beta1 and fingolimod therapy;Acar;Journal of Neuroimmunology,2020

2. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Therapeutic Advances in Neurological Disorders,2021

3. Downregulation of sphingosine 1-phosphate receptor 1 promotes the switch from tangential to radial migration in the OB;Alfonso;The Journal of Neuroscience,2015

4. S1P1 receptor directs the release of immature B cells from bone marrow into blood;Allende;The Journal of Experimental Medicine,2010

5. Fingolimod does not enhance cerebellar remyelination in the cuprizone model;Alme;Journal of Neuroimmunology,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astrocyte-derived clusterin disrupts glial physiology to obstruct remyelination in mouse models of demyelinating diseases;Nature Communications;2024-09-06

2. Siponimod treatment response shows partial BDNF dependency in multiple sclerosis models;Scientific Reports;2024-08-01

3. Novel Compounds as S1P5 Modulators for Treating Neurodegenerative Diseases;ACS Medicinal Chemistry Letters;2024-05-05

4. The mitochondriogenic but not the immunosuppressant effects of mTOR inhibitors prompt neuroprotection and delay disease evolution in a mouse model of progressive multiple sclerosis;Neurobiology of Disease;2024-02

5. Sphingosine 1-phosphate signaling during infection and immunity;Progress in Lipid Research;2023-11